Zoetis
Vanguard CIV Canine Influenza Vaccine (H3N2), Killed Virus
Vanguard CIV Canine Influenza Vaccine (H3N2), Killed Virus
Low stock: 10 left
For vaccination of healthy dogs 8 weeks of age or older against canine influenza (H3N2) virus infection. This product contains the canine influenza strains A/Illinois/12191/2015 (H3N2).
CIV vaccines do not cross-protect against the two known circulating strains in the United States. Zoetis strongly recommends that these vaccines be used only used if a dog is lacking vaccination against one of the two strains, and then continue with the use of Vanguard CIV H3N2/H3N8.
- Canine immune response to CIV can be severe and result in suppurative pneumonia and cell death.1-3 Vaccination can help prevent coinfections and worsening clinical morbidity as well as prevent or reduce subclinical lung lesions.4-6
- Killed vaccine cannot transmit CIV because it is unable to replicate to cause disease; therefore safe for administration around immunocompromised pet owners/veterinary staff.
Healthy dogs should receive 2 doses administered 3 weeks apart. Historically, annual
revaccination with this product was recommended. The need for annual booster
vaccinations has not been established for this product; consultation with a veterinarian or the manufacturer is recommended.
WARNING: This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products. In case of human exposure, contact a physician.
